Skip to content

Insider · CIK 0001240014

Edward C Albini

cfoofficer

Files at STRO (SUTRO BIOPHARMA, INC.). First filing -, latest -.

Edward C Albini files SEC Form 4 as CFO at STRO (SUTRO BIOPHARMA, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Edward C Albini has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 18 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 15, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Common Stock
+24,438$0.00$0156,519May 19, 2025
May 15, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Common Stock
+11,156$0.00$0167,675May 19, 2025
May 15, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Common Stock
+9,125$0.00$0176,800May 19, 2025
May 15, 2025STRO
SUTRO BIOPHARMA, INC.
FTax withholding
Common Stock
-15,995$0.88$14k160,805May 19, 2025
May 15, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Restricted Stock Unit (RSU)derivative
-24,438$0.00$027,312May 19, 2025
May 15, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Restricted Stock Unit (RSU)derivative
-11,156$0.00$04,594May 19, 2025
May 15, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Restricted Stock Unit (RSU)derivative
-9,125$0.00$00May 19, 2025
Mar 5, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Common Stock
+8,750$0.00$0135,675Mar 7, 2025
Mar 5, 2025STRO
SUTRO BIOPHARMA, INC.
FTax withholding
Common Stock
-3,594$1.36$4,888132,081Mar 7, 2025
Mar 5, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Restricted Stock Unit (RSU)derivative
-8,750$0.00$00Mar 7, 2025
Mar 4, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Common Stock
+9,125$0.00$0130,673Mar 6, 2025
Mar 4, 2025STRO
SUTRO BIOPHARMA, INC.
FTax withholding
Common Stock
-3,748$1.42$5,322126,925Mar 6, 2025
Mar 4, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Restricted Stock Unit (RSU)derivative
-9,125$0.00$09,125Mar 6, 2025
Mar 1, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Common Stock
+7,875$0.00$0114,618Mar 4, 2025
Mar 1, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Common Stock
+17,250$0.00$0131,868Mar 4, 2025
Mar 1, 2025STRO
SUTRO BIOPHARMA, INC.
FTax withholding
Common Stock
-10,320$1.59$16k121,548Mar 4, 2025
Mar 1, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Restricted Stock Unit (RSU)derivative
-7,875$0.00$015,750Mar 4, 2025
Mar 1, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Restricted Stock Unit (RSU)derivative
-17,250$0.00$051,750Mar 4, 2025

Questions about Edward C Albini

Answered from the filings on this page, as of the latest one.

Is Edward C Albini buying or selling?

Edward C Albini has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Edward C Albini's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Edward C Albini has 0.

Where does Edward C Albini file Form 4?

Edward C Albini has filed Form 4 at STRO (SUTRO BIOPHARMA, INC.) as CFO AND SECRETARY. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Edward C Albini: insider trades and track record | InsiderTell